Fibrogenic Signaling Is Suppressed in Hepatic Stellate Cells through Targeting of Connective Tissue Growth Factor (CCN2) by Cellular or Exosomal MicroRNA-199a-5p-Reference-Cited by-同舟云学术

Fibrogenic Signaling Is Suppressed in Hepatic Stellate Cells through Targeting of Connective Tissue Growth Factor (CCN2) by Cellular or Exosomal MicroRNA-199a-5p

Published:2016-11 Issue:11 Volume:186 Page:2921-2933
ISSN:0002-9440
Container-title:The American Journal of Pathology
language:en
Short-container-title:The American Journal of Pathology

Author:

Chen Li,Chen Ruju,Velazquez Victoria M.,Brigstock David R.

Funder

NIH

Publisher

Elsevier BV

Subject

Pathology and Forensic Medicine

Reference61 articles.

1. Hepatic fibrosis – overview;Friedman;Toxicology,2008

2. Mechanisms of hepatic fibrogenesis;Friedman;Gastroenterology,2008

3. Antifibrotic therapies: where are we now?;Yoon;Semin Liver Dis,2016

4. Promising therapy candidates for liver fibrosis;Wang;Front Physiol,2016

5. Hepatic fibrosis: emerging therapies;Friedman;Dig Dis,2015

Cited by 61 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Extracellular Vesicles, Circadian Rhythms, and Cancer: A Comprehensive Review with Emphasis on Hepatocellular Carcinoma;Cancers;2024-07-16

2. Sinusoidal cell interactions—From soluble factors to exosomes;Sinusoidal Cells in Liver Diseases;2024

3. HSC-derived exosomal miR-199a-5p promotes HSC activation and hepatocyte EMT via targeting SIRT1 in hepatic fibrosis;International Immunopharmacology;2023-11

4. MicroRNAs and Nonalcoholic Steatohepatitis: A Review;International Journal of Molecular Sciences;2023-09-23

5. Formation and Investigation of Cell‐Derived Nanovesicles as Potential Therapeutics against Chronic Liver Disease;Advanced Healthcare Materials;2023-09-17